Michael Schöll

Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
A. Caroli, A. Prestia, S. Galluzzi, C. Ferrari, W. M. van der Flier et al.
Neurology, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

MILD COGNITIVE IMPAIRMENT WITH SUSPECTED NON AD PATHOLOGY (SNAP): PREDICTION OF PROGRESSION TO DEMENTIA
Anna Caroli, Giovanni Frisoni, Annapaola Prestia, Samantha Galluzzi, Clarissa Ferrari et al.
Alzheimer's & Dementia. 10 (4), s. P194-P195, Paper i proceeding 2014
Paper i proceeding

Fluorodeoxyglucose PET in Neurology and Psychiatry
Michael Schöll, A. Damian, H. Engler
PET Clinics, Artikel i vetenskaplig tidskrift 2014
Artikel i vetenskaplig tidskrift

Astrocytosis measured by C-11-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients
I. L. H. Choo, S. F. Carter, Michael Schöll, A. Nordberg
European Journal of Nuclear Medicine and Molecular Imaging, Artikel i vetenskaplig tidskrift 2014
Artikel i vetenskaplig tidskrift

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.
Annapaola Prestia, Anna Caroli, Wiesje M van der Flier, Rik Ossenkoppele, Bart Van Berckel et al.
Neurology, Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
Il Han Choo, Ruiqing Ni, Michael Schöll, Anders Wall, Ove Almkvist et al.
Journal of Alzheimer's disease : JAD, Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
Michael Schöll, Anders Wall, Steinunn Thordardottir, Daniel Ferreira, Nenad Bogdanovic et al.
Neurology, Artikel i vetenskaplig tidskrift 2012
Artikel i vetenskaplig tidskrift

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
Stephen F Carter, Michael Schöll, Ove Almkvist, Anders Wall, Henry Engler et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Artikel i vetenskaplig tidskrift 2012
Artikel i vetenskaplig tidskrift

Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG
Stephen F. Carter, Agneta Nordberg, Michael Schöll, Ove Almkvist, Anders Wall et al.
Alzheimer's & Dementia. 7 (4), s. S110, Paper i proceeding 2011
Paper i proceeding

Different hierarchical cytoarchitectonic sub-type vulnerability to Aβ-deposits and gray matter loss in AD and MCI patients: A comparison between a young and old cohort
Yen-Bee Ng, Agneta Nordberg, Stephen Carter, Michael Schöll, Ahmadul Kadir
Alzheimer's & Dementia. 7 (4), s. e37-e38, Paper i proceeding 2011
Paper i proceeding

Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
A. Caroli, A. Prestia, S. Galluzzi, C. Ferrari, W. M. van der Flier et al.
Neurology, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

MILD COGNITIVE IMPAIRMENT WITH SUSPECTED NON AD PATHOLOGY (SNAP): PREDICTION OF PROGRESSION TO DEMENTIA
Anna Caroli, Giovanni Frisoni, Annapaola Prestia, Samantha Galluzzi, Clarissa Ferrari et al.
Alzheimer's & Dementia. 10 (4), s. P194-P195, Paper i proceeding 2014
Paper i proceeding

Fluorodeoxyglucose PET in Neurology and Psychiatry
Michael Schöll, A. Damian, H. Engler
PET Clinics, Artikel i vetenskaplig tidskrift 2014
Artikel i vetenskaplig tidskrift

Astrocytosis measured by C-11-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients
I. L. H. Choo, S. F. Carter, Michael Schöll, A. Nordberg
European Journal of Nuclear Medicine and Molecular Imaging, Artikel i vetenskaplig tidskrift 2014
Artikel i vetenskaplig tidskrift

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.
Annapaola Prestia, Anna Caroli, Wiesje M van der Flier, Rik Ossenkoppele, Bart Van Berckel et al.
Neurology, Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
Il Han Choo, Ruiqing Ni, Michael Schöll, Anders Wall, Ove Almkvist et al.
Journal of Alzheimer's disease : JAD, Artikel i vetenskaplig tidskrift 2013
Artikel i vetenskaplig tidskrift

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
Michael Schöll, Anders Wall, Steinunn Thordardottir, Daniel Ferreira, Nenad Bogdanovic et al.
Neurology, Artikel i vetenskaplig tidskrift 2012
Artikel i vetenskaplig tidskrift

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
Stephen F Carter, Michael Schöll, Ove Almkvist, Anders Wall, Henry Engler et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Artikel i vetenskaplig tidskrift 2012
Artikel i vetenskaplig tidskrift

Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG
Stephen F. Carter, Agneta Nordberg, Michael Schöll, Ove Almkvist, Anders Wall et al.
Alzheimer's & Dementia. 7 (4), s. S110, Paper i proceeding 2011
Paper i proceeding

Different hierarchical cytoarchitectonic sub-type vulnerability to Aβ-deposits and gray matter loss in AD and MCI patients: A comparison between a young and old cohort
Yen-Bee Ng, Agneta Nordberg, Stephen Carter, Michael Schöll, Ahmadul Kadir
Alzheimer's & Dementia. 7 (4), s. e37-e38, Paper i proceeding 2011
Paper i proceeding